$0.61
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. The company is headquartered in Santa Clara, California and currently employs 16 full-time employees. The company went IPO on 2021-10-14. The firm focuses on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. The company is engaged in the development of higher resolution ECG solutions is achieved through the development of the Company’s proprietary and patented electrocardiography technology platform. The company is developing three-dimensional (3D) representations of cardiac electrical activity by displaying the spatial locations of ECG waveforms. The company is developing its own product, the HeartBeam System. The HeartBeam System comprises a credit card sized 12-lead output electrocardiogram device, a patient application, a physician portal, and powerful cloud-based algorithms. The core technology consists of a series of patented inventions that allow it to capture the heart’s electrical activity from three distinct directions.
Country

US

CEO

Mr. Robert Eno

IPO date

2021

Employees

16

ISIN

US42238H1086

Key stats

Open

$0.62

Volume

286.55K

Market cap

$35.52M

Prev. close

$0.64

Impl / hst vl

-

Open interest

$0.00

$0.60

Day’s Range

$0.64

$0.60

52W Range

$2.88

Valuation

16
Valuation score
Strongly Overvalued
P/E
-
P/S
-
P/B
55.94
Current ratio
0.74
Debt / Equity
-3.21
ROE
-1,034.04%
Gross margin
-
Income growth
-11.35%
FCF growth
16.07

Analysts estimates

Consensus rating
Buy

The average rating from top 6 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$3.91
The top 5 analysts forecasts that 12-month price may increase by 540.98%, with a low of $2.53 and a high of $5.25
$2.53
Low
$3.91
Avg
$5.25
High
Current price

Earnings

Q1 ‘26 revenue
$0.00
Q1 ‘26 net income
-$4.70M
Revenue
Net income
Previous EPS
-$0.12
Estimate EPS
-$0.10
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply